Quick Answer
Sarepta Therapeutics, Inc. reported Common Stock Shares Outstanding of 104.96 million shares for the year ending 2025.
- Sarepta Therapeutics, Inc. showed an increase of +8.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Sarepta Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Sarepta Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 6.6%.
- Historical annual values: Fiscal year 2025: 104.96 million shares | Fiscal year 2024: 96.90 million shares | Fiscal year 2023: 93.73 million shares | Fiscal year 2022: 87.95 million shares | Fiscal year 2021: 87.13 million shares | Fiscal year 2020: 79.37 million shares | Fiscal year 2019: 75.18 million shares | Fiscal year 2018: 71.07 million shares | Fiscal year 2017: 64.79 million shares | Fiscal year 2016: 54.76 million shares | Fiscal year 2015: 45.63 million shares | Fiscal year 2014: 41.31 million shares | Fiscal year 2013: 37.75 million shares | Fiscal year 2012: 31.70 million shares | Fiscal year 2011: 22.62 million shares | Fiscal year 2010: 112.35 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: